Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell Lymphoma

about

Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell Lymphoma

Item

http://www.wikidata.org/entity/Q36522482

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Fatal Hepatocellular Carcinoma ...... Diffuse Large B-Cell Lymphoma

@ast

Fatal Hepatocellular Carcinoma ...... Diffuse Large B-Cell Lymphoma

@en

type

Item

label

Fatal Hepatocellular Carcinoma ...... Diffuse Large B-Cell Lymphoma

@ast

Fatal Hepatocellular Carcinoma ...... Diffuse Large B-Cell Lymphoma

@en

prefLabel

Fatal Hepatocellular Carcinoma ...... Diffuse Large B-Cell Lymphoma

@ast

Fatal Hepatocellular Carcinoma ...... Diffuse Large B-Cell Lymphoma

@en

P1476

Fatal Hepatocellular Carcinoma ...... Diffuse Large B-Cell Lymphoma

@en

P2093

Carmela Arrigo

http://www.w3.org/2001/XMLSchema#string

Giuseppe Altavilla

http://www.w3.org/2001/XMLSchema#string

Massimo Rizzo

http://www.w3.org/2001/XMLSchema#string

Patrizia Mondello

http://www.w3.org/2001/XMLSchema#string

Vincenzo Pitini

http://www.w3.org/2001/XMLSchema#string

P2860

Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.

Occult hepatitis B.

Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports

Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C.

Mechanisms of therapy-related carcinogenesis.

Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections.

Long-term complications of lymphoma and its treatment.

Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China.

Statements from the Taormina expert meeting on occult hepatitis B virus infection.

Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis.

P304

803298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/803298

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234159271

http://www.w3.org/2001/XMLSchema#string

P698

23326737

http://www.w3.org/2001/XMLSchema#string

P932

3541567

http://www.w3.org/2001/XMLSchema#string